ASCO 2011: MDxHealth’s brain cancer companion diagnostic proves itself in Phase III study
This article was originally published in Clinica
Executive Summary
PredictMDx for Brain, a companion diagnostic developed by personalised cancer test specialist MDxHealth, has demonstrated its ability to identify glioblastoma patients who are most responsive to treatment.